<DOC>
	<DOCNO>NCT02094859</DOCNO>
	<brief_summary>The primary purpose Study evaluation safety performance GlucoClear System ( System ) . The primary safety objective assess : • Evaluation serious adverse device effect upon Sensor insertion Sensor removal follow-up assessment one week ( 7 ± 3 day ) Sensor removal . The primary performance objective evaluate use follow criterion : 15/20 % Performance : Blood glucose measurement System must meet ISO 15197 15/20 % accuracy criterion ( least 95 % match pair within ± 15 mg/dL Comparator value ≤ 75 mg/dL within ±20 % Comparator value &gt; 75 mg/dL ) .</brief_summary>
	<brief_title>GlucoClearTM System ICU Study</brief_title>
	<detailed_description>Design : Non-randomized , non-treatment , prospective , open label Study . After provide write informed consent , subject meet Inclusion/Exclusion Criteria connect System maximum 72 hour . For purpose clinical Study , System display real-time glucose value , glucose trend graph , glucose alarm either Study Subjects Study Site Personnel . There treatment Subject base output System . Diabetes management decision throughout Study ( applicable ) conduct accord hospital procedure . - 1 set laboratory measurement draw per Subject baseline . - A maximum 82 blood sample draw per Subject 72 hour monitoring session include . - Up 75 blood sample draw comparative glucose measurement laboratory analyzer . Blood sample take sample catheter peripheral vein contralateral extremity ( relative placement System ) 25 sample take within one day ( 00:00 23:59 ) glucose measurement laboratory analyzer ( e.g. , Yellow Springs Instrument glucose analyzer ( YSI ) , Radiometer blood analyzer ) ; - Up three ( 3 ) set laboratory measurement ; - Up 4 blood sample , need . One week ( 7 + 3 day ) Sensor removal , subject contact follow-up assessment document subsequent adverse event .</detailed_description>
	<criteria>≥ 18 year ICU ≥ 24 hour Signed consent Transplant patient Brain injury/surgery patient End stage medical condition disease Restricted venous access History HIT Contraindication anticoagulation bleed disorder Positive pregnancy test In drug , device , biologic study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Glucose Monitoring</keyword>
</DOC>